Neoplasia · Nov 2026
Obstructive Sleep Apnea and Lung Cancer Risk: A Systematic Review with Meta-Analysis
By He H, Chen S, Ren Q et al.
Background This relationship between obstructive sleep apnea (OSA) and lung malignancy has been reported previously, but remains controversial. The aim of this systematic review is to evaluate the hypothesis that OSAs is a potential hazard for the development of lung cancer. Methods We performed a structured review in PubMed, Cochrane Library, Embase and Web of Science databases from inception through September 2024 to yield the data underlying a comparison of lung cancer risk in individuals with and without OSA. Aggregated hazard ratios (HRs) along with 95% confidence intervals (CIs) were determined utilizing random-effects statistical models. Results The systematic review included eight cohort studies. Of these, 7 studies with adjusted HR and RR were included in the meta analysis (N = 7,641,402), which showed robust association with higher lung Cancer incidence (HR = 1.24, 95% CI: 1.03–1.49), and higher risk in studies with a six to nine-year followup (HR = 1.32, 95% CI: 1.27–1.38). Findings were generally robust having been supported by sensitivity analysis. There was a lack of robust power of the publication-bias tests as the number of studies in the analyses was low (P = 0.744 for Egger’s test). Six studies that used a retrospective group design showed similar patterns (HR = 1.21, 95% CI: 0.99–1.47). Conclusions OSA is associated with an elevated risk for cancer of the lungs, particularly during mid-term follow-up (6–9 years). The large standard deviation emphasises the need for a standardised procedure for the implementation of OSA screening and covariate adjustments in follow-up trials.